Webinar: Where are the developments in cancer research?
This free webinar at 3pm BST on 12 June, hosted by DDW and sponsored by Scale Biosciences, will see experts and thought-leaders from the cancer research sector discuss where innovation is occurring and what the challenges are to overcome for drug discovery projects in the oncology field.
Presenters include Roy Maute, CEO and co-founder of Pheast Therapeutics, and Rachel Grimley, Senior Vice President of Drug Discovery at Cancer Research UK.
Dr Roy Maute will explore how targeting CD24 as a macrophage checkpoint opens a novel axis in innate immune drug discovery for cancer. He will share insights from the development of PHST001, Pheast’s clinical-stage anti-CD24 antibody, and discuss how modulating myeloid biology may overcome resistance to current immunotherapies and deliver durable responses in solid tumours.
Throughout this webinar, you will learn:
- Where we are seeing key drug discovery developments in cancer research
- How technology, like AI, is helping to map out new targets
- Where we are likely to see significant breakthroughs in cancer research drug discovery
- What challenges the sector faces and what can be done to overcome them
Register for free now to secure your place at the webinar!